Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Published:2020-03-03 Issue:9 Volume:323 Page:844
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Wouters Olivier J.¹,McKee Martin²,Luyten Jeroen³

Affiliation:

1. Department of Health Policy, London School of Economics and Political Science, London, United Kingdom

2. Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom

3. Leuven Institute for Healthcare Policy, Department of Public Health and Primary Care, KU Leuven, Belgium

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2762311/jama_wouters_2020_oi_200015.pdf

Reference31 articles.

1. The high cost of prescription drugs in the United States: origins and prospects for reform.;Kesselheim;JAMA,2016

2. The cost of drug development: a systematic review.;Morgan;Health Policy,2011

3. The price of innovation: new estimates of drug development costs.;DiMasi;J Health Econ,2003

4. Innovation in the pharmaceutical industry: new estimates of R&D costs.;DiMasi;J Health Econ,2016

5. Estimating the clinical cost of drug development for orphan versus non-orphan drugs.;Jayasundara;Orphanet J Rare Dis,2019

Cited by 853 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The changing regulatory environment: regulations and restrictions;OrthoBiologics;2025

2. GETdb: A comprehensive database for genetic and evolutionary features of drug targets;Computational and Structural Biotechnology Journal;2024-12

3. Globalization of clinical research in oncology: Status, challenges, and future directions;Journal of Cancer Policy;2024-12

4. Databases of ligand-binding pockets and protein-ligand interactions;Computational and Structural Biotechnology Journal;2024-12

5. Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors;Computational and Structural Biotechnology Journal;2024-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3